---
title: "King International Investment Adds Governance Details on New Co-Chairman Wang"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/272330038.md"
description: "King International Investment Limited has disclosed additional details regarding the appointment of Mr. Wang as co-chairman and executive director. He is also the president and controlling shareholder of Yubo International Biotech Limited and briefly served as an executive director of Easy Smart Group Holdings Limited in 2025. The announcement clarifies that Mr. Wang has not held directorships in other listed companies in the past three years, enhancing transparency on the company's governance structure. King International Investment is a Cayman Islands-incorporated investment holding company listed in Hong Kong, engaging in diversified investment activities."
datetime: "2026-01-12T23:11:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272330038.md)
  - [en](https://longbridge.com/en/news/272330038.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272330038.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/272330038.md) | [繁體中文](https://longbridge.com/zh-HK/news/272330038.md)


# King International Investment Adds Governance Details on New Co-Chairman Wang

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Life Healthcare Group ( (HK:0928) ) just unveiled an announcement.

King International Investment Limited has provided additional disclosure regarding the appointment of Mr. Wang as an executive director and co-chairman of the board, clarifying that he is president, director and controlling shareholder of U.S.-listed Yubo International Biotech Limited, and that he briefly served as an executive director of Easy Smart Group Holdings Limited in 2025. The supplemental announcement confirms that, apart from these roles, Mr. Wang has not held directorships in other listed companies over the past three years and that all other details of his appointment remain unchanged, offering investors more transparency on the governance and leadership profile of the Hong Kong–listed group.

**More about Life Healthcare Group**

King International Investment Limited is an investment holding company incorporated in the Cayman Islands and listed in Hong Kong. Through its subsidiaries, the Group engages in diversified investment activities, and its board comprises both executive and independent non-executive directors, reflecting a typical governance structure for mid-cap Hong Kong–listed investment firms.

**Average Trading Volume:** 1,753,036

**Technical Sentiment Signal:** Hold

**Current Market Cap:** HK$168.4M

For an in-depth examination of 0928 stock, go to TipRanks’ Overview page.

### 相关股票

- [Yubo International Biotech Limited (YBGJ.US)](https://longbridge.com/zh-CN/quote/YBGJ.US.md)

## 相关资讯与研究

- [Vitalist to Acquire Somatix, Pushing VitalOS Deeper Into Medical Wearables](https://longbridge.com/zh-CN/news/281221945.md)
- [There’s Been A Staggering Number Of Deaths In ICE Custody During Trump’s Second Term](https://longbridge.com/zh-CN/news/281293924.md)
- [13:32 ETApploi Ranks No. 91 on Inc. Magazine's List of the Northeast Region's Fastest-Growing Private Companies in America](https://longbridge.com/zh-CN/news/281224890.md)
- [Assessing ArriVent BioPharma (AVBP) Valuation After Recent Share Price Momentum Shift](https://longbridge.com/zh-CN/news/280879192.md)
- [Does New NefIgArd Phase 3 IgAN Data Shift The Bull Case For Asahi Kasei (TSE:3407)?](https://longbridge.com/zh-CN/news/281447269.md)